What are the causes of low luteinizing hormone (LH) levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Causes of Low LH

Low luteinizing hormone (LH) levels result from either central hypogonadism (hypothalamic-pituitary dysfunction) or functional suppression, with the most common causes being pituitary/hypothalamic tumors, exogenous testosterone/steroid use, functional hypothalamic amenorrhea, hyperprolactinemia, and obesity-related hypogonadotropism.

Central (Organic) Causes

Pituitary and Hypothalamic Pathology

The most frequent structural causes of low LH include:

  • Pituitary adenomas (especially macroadenomas and craniopharyngiomas) - prevalence of central hypogonadism can reach 95% in patients with sellar tumors 1
  • Post-surgical hypopituitarism - up to 57% develop central hypogonadism after pituitary surgery 1
  • Cranial radiation - high prevalence after radiotherapy for both sellar and non-sellar brain tumors, though onset may take years to develop 1
  • Traumatic brain injury and stroke - increasing in prevalence as survival rates improve 1
  • Infiltrative lesions - including inflammatory, autoimmune, and infectious processes 1

Genetic and Congenital Disorders

Very low or undetectable LH levels suggest organic hypothalamic amenorrhea from genetic mutations affecting GnRH ontogeny and function 2. These patients show impaired acute LH response to GnRH stimulation, distinguishing them from functional causes.

Functional (Reversible) Causes

Functional Hypothalamic Amenorrhea (FHA)

This presents with characteristically low or low-normal LH with normal FSH concentrations (FSH usually higher than LH), estradiol <50 pg/mL, and preserved acute gonadotropin response to GnRH stimulation 2. Key triggers include:

  • Energy deficit from excessive exercise or caloric restriction
  • Psychological stress
  • Low body weight

Critical distinction: In FHA, the GnRH response remains intact (2-3 fold rise in LH/FSH), whereas true hypogonadotropic hypogonadism shows blunted acute LH response 2.

Hyperprolactinemia

Elevated prolactin from tumors or medications commonly suppresses LH secretion 1. Prolactin >100 ng/mL warrants additional evaluation for prolactinoma or other pathology 2.

Exogenous Hormone Suppression

  • Testosterone therapy: 73% of men experience at least one episode of LH <1.0 IU/L during treatment, though only 22% maintain persistent suppression 3. Intramuscular testosterone causes greater suppression than transdermal formulations.
  • Exogenous glucocorticoids: The most common cause of central adrenal insufficiency, which often coexists with gonadotropin deficiency 1

Obesity-Related Hypogonadotropism

Obesity causes attenuated LH pulse amplitude while maintaining normal pulse frequency 4. The mechanism involves:

  • Negative correlation between body mass index and free testosterone (P < 0.001) 4
  • Decreased LH pulse amplitude inversely related to insulin resistance severity 5
  • Weight reduction decreases LH by 45% in severely overweight patients, with the magnitude inversely correlated to insulin sensitivity 5

Important: The LH/FSH ratio decreases with weight loss, favoring FSH predominance and improved folliculogenesis 5.

Clinical Patterns for Diagnosis

Hormone Pattern Recognition

The pattern matters more than absolute values 2:

  • FHA: Low/low-normal LH, normal FSH (FSH > LH), estradiol <50 pg/mL, preserved GnRH response
  • Organic hypogonadotropic hypogonadism: Very low/undetectable LH and FSH, blunted GnRH response
  • Hyperprolactinemia: Suppressed LH with prolactin elevation
  • Obesity: Decreased LH pulse amplitude, elevated insulin, low testosterone

Essential Workup

When evaluating low LH, obtain 2:

  • TSH, free T4 (to exclude thyroid dysfunction)
  • Prolactin (rule out hyperprolactinemia)
  • FSH (assess pattern relative to LH)
  • Estradiol (females) or testosterone (males)
  • Consider GnRH stimulation test if differentiating FHA from organic causes

Critical Clinical Implications

Untreated gonadotropin deficiency increases mortality (hazard ratio 1.86), while sex steroid replacement significantly reduces standardized mortality ratio from 2.97 to 1.42 1. Early menopause and bilateral oophorectomy before age 45 without estrogen replacement increase cardiovascular mortality 1.

Common Pitfalls

  • Assuming all low LH represents permanent hypogonadotropic hypogonadism without considering reversible causes
  • Missing functional causes (stress, weight changes, medications) that respond to lifestyle modification
  • Failing to check prolactin in all cases of low LH
  • Not recognizing that obesity-related hypogonadism improves with weight loss and insulin sensitivity enhancement 5
  • Overlooking delayed onset of hypopituitarism years after cranial radiation 1

References

2
Guideline

functional hypothalamic amenorrhea: an endocrine society clinical practice guideline.

The Journal of clinical endocrinology and metabolism, 2017

Related Questions

What is the normal reference range for luteinizing hormone (LH)?
What are the causes, diagnostic work‑up, and management options for low luteinising hormone (LH)?
When should serum luteinizing hormone (LH) be checked in men?
How should a low follicle‑stimulating hormone (FSH) level be interpreted together with the other hormonal labs (LH, estradiol, prolactin, TSH, AMH) and what management is recommended?
What causes low Follicle-Stimulating Hormone (FSH) and Luteinizing Hormone (LH) levels?
What is the appropriate treatment for a post‑viral cough in a 17‑kg child with a normal white‑cell count (~5 000/µL) and normal platelet count (~200 000/µL)?
How should systemic sclerosis be diagnosed and managed, including therapy for skin involvement, interstitial lung disease, Raynaud phenomenon, pulmonary arterial hypertension, renal crisis, and gastrointestinal manifestations?
What factors contribute to the development of borderline personality disorder?
Can I discontinue fluoxetine (Prozac) and buspirone (Buspar) if I am experiencing side effects?
What is the appropriate initial management for a patient with Raynaud's phenomenon, microstomia, and anti‑RNP antibody positivity?
What is the safest 48‑hour postoperative multimodal analgesic regimen for a patient with stage 2 chronic kidney disease?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.